🇮🇳IN
Sign In
BL

BLISSGVS

NSE

Bliss GVS Pharma Ltd

₹623.35

-19.35(-3.01%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

BLISSGVS financial summary

For Mar 2026, Bliss GVS Pharma Ltd reported revenue of ₹730 crore, which grew 9.4% from the previous year. Net profit was ₹97 crore, which grew 40.6% year on year, on an operating margin of 18%. Earnings per share came in at ₹9.16. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.

Revenue₹730 crore
Net profit₹97 crore
Operating margin18%
EPS₹9.16

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer